Cannabics looking to the future and using cannabinoids to fight cancer

Cannabics Pharmaceuticals Inc (OTCQB:CNBX) CEO and Co-Founder Eyal Barad spoke with Proactive Investors at the ThinkEquity Conference in New York. The Israeli-based company is developing a platform that leverages drug-screening tools and artificial intelligence to create cannabinoid-based therapies for cancer.

source